Amazon removes 7 eye drop products after FDA warning
Amazon is removing seven eye-drop products from its e-commerce site after the Food and Drug Administration warned the company that the products were unapproved, the company announced Wednesday.
In a Nov. 13 letter to Amazon chief executive Andrew Jassy, the FDA said that the unapproved products were “especially concerning from a public health perspective” because they are administered through the eyes and can bypass the body’s natural defenses.
Amazon said in a statement that the products cited by the FDA “have been investigated and are in the process of being removed.”
“Safety is a top priority at Amazon. We require all products offered in our store to comply with applicable laws and regulations,” the company said. (Amazon founder Jeff Bezos owns The Washington Post. Interim Washington Post chief executive Patty Stonesifer sits on Amazon’s board.)
Advertisement
The FDA listed these products:
Share this articleShare- Similasan Pink Eye Relief
- The Goodbye Company Pink Eye
- Can-C Eye Drops
- Optique 1 Eye Drops
- OcluMed Eye Drops
- TRP Natural Eye Floaters Relief
- Manzanilla Sophia Chamomile Herbal Eye Drops
Less than a month ago, the FDA issued a warning that 26 eye-drop products risked causing vision loss or blindness. CVS Health, Rite Aid and Target subsequently removed the products from their shelves and online stores. Previously this year, an outbreak of serious bacterial infections, resulting in at least 14 cases of permanent vision loss and four deaths, prompted two voluntary eye-care product recalls.
Millions of Americans use eye drops for conditions such as glaucoma and allergies, and medical experts say most of the products are safe.
Marlene Cimons and Teddy Amenabar contributed to this report.
ncG1vNJzZmivp6x7uK3SoaCnn6Sku7G70q1lnKedZK%2B2v8innKyrX2d9c3%2BOamhoaWVksrqxjJ2pqKhdlrqixs6nZJ%2BckWLEor7NoqWgZw%3D%3D